Fast science—with all its warts—is making unprecedented progress in the fight against COVID-19.

Despite high-profile political tensions between the two countries, researchers in the US and China are working together now more than ever, according to our bibliometric study.

What we can and must do to make science more equitable.

Accounting for a limited stockpile of cholera vaccine can provide insight into the most effective way to distribute future COVID-19 vaccines.

Our handbook on best practices for quality assurance in biomedicine can help funding agencies shore up research integrity—which is especially needed at a time when mistakes can have outsize effects.

Among the disruptions and pain caused by the COVID-19 pandemic, researchers are dealing with a sudden halt in in-person interactions.

If governments were to use SARS-CoV-2 antibody tests to manage who can re-enter the workplace, society must accept a sacrifice of privacy.

We mourned the closing of our lab. But then we got back to work—finding the balance between scholarly relevance and adapting to life in a world of new social norms.

Here’s how my group put our research on pause and how we’ve continued our work from home.